Li AJ, Dhanraj JP, Lopes G, Parker JL. › Clinical Trial Risk in Leukæmia: Biomarkers and Trial Design. Hematological Oncology, 2021; 39(1):105-113. › 10.1002/hon.2818 Impact factor: 2·8 Alice Li ♙ lead author, Class of 2021 Jasper Dhanraj ♙ co-author, Class of 2021...
Siddhi Manjrekar ♙Class of 2021 Luqmaan Mohamed, Siddhi Manjrekar, Derek P Ng, Alec Walsh, Gilberto Lopes, Jayson L Parker › The Effect of Biomarker Use on the Speed and Duration of Clinical Trials for Cancer Drugs The Oncologist, 2022, 27(10), 849-856›...
Parker JL, Kuzulugil SS, Pereverzev K, Mac S, Lopes G, Shah Z, Weerasinghe A, Rubinger D, Falconi A, Bener A, Caglayan B, Tangri R & Mitsakakis N › Does Biomarker Use in Oncology Improve Clinical Trial Failure Risk? A Large-scale Analysis. Cancer Medicine, 2021;...
